The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $37.59

Today's change-2.48 -6.19%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
 

Seattle Genetics Inc

Nasdaq: SGEN
Last

(U.S.) $37.59

Today's change-2.48 -6.19%
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.

Seattle Genetics Inc crosses below 200-day moving average

Seattle Genetics Inc closed sharply lower Friday, dropping (U.S.)$2.48 or 6.19% to (U.S.)$37.59 and crossing below its 200-day moving average. Although unchanged over the last five days, shares are down 16.24% for the last year to date. This security has underperformed the S&P 500 by 18.34% during the last year.

Key company metrics

  • Open(U.S.) $38.00
  • Previous close(U.S.) $40.07
  • High(U.S.) $39.43
  • Low(U.S.) $37.50
  • Bid / Ask(U.S.) $32.95 / (U.S.) $39.31
  • YTD % change-16.24%
  • Volume1,045,075
  • Average volume (10-day)875,491
  • Average volume (1-month)937,587
  • Average volume (3-month)1,045,001
  • 52-week range(U.S.) $26.02 to (U.S.) $52.33
  • Beta1.76
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.91
Updated June 24 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue111938477
Total other revenue--------
Total revenue111938477
Gross profit102837469
Total cost of revenue1010109
Total operating expense132119111125
Selling / general / administrative30343030
Research & development93757186
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-21-25-27-48
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-20-25-26-48
Income after tax-20-25-26-48
Income tax, total--------
Net income-20-25-26-48
Total adjustments to net income--------
Net income before extra. items-20-25-26-48
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-20-25-26-48
Inc. avail. to common incl. extra. items-20-25-26-48
Diluted net income-20-25-26-48
Dilution adjustment--------
Diluted weighted average shares140140128125
Diluted EPS excluding extraordinary itemsvalue per share-0.15-0.18-0.21-0.38
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.15-0.18-0.21-0.38